FDA REVIEWING REGULATORY STATUS OF ALPHA HYDROXY ACID PRODUCTS
This article was originally published in The Tan Sheet
Executive Summary
FDA REVIEWING REGULATORY STATUS OF ALPHA HYDROXY ACID PRODUCTS to determine if they should be regulated as drugs or cosmetics. Commenting on the issue at the Food & Drug Law Institute's Annual Educational Conference Dec. 15, FDA Office of Cosmetics and Colors Acting Director John Bailey, PhD, explained that "the question here is: are these products drugs or cosmetics? This, of course, depends primarily upon the intended use as established through labeling; however,...another factor [that] can be considered is the actual effect, if any, upon the structure and function of the body."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning